PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML

Detalles Bibliográficos
Autores principales: Daver, N., Maris, M., Ramchandren, R., Bixby, D., Doucette, K., Mawad, R., Egan, D., Stevens, D., Zonder, J., Molloy, N., Scheuber, A., Bruns, I., Mantzaris, I., Konopleva, M., Goldberg, A. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430693/
http://dx.doi.org/10.1097/01.HS9.0000850132.55221.5c

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430693/
http://dx.doi.org/10.1097/01.HS9.0000850132.55221.5c

Ejemplares similares